JPS5132725A - - Google Patents

Info

Publication number
JPS5132725A
JPS5132725A JP50040754A JP4075475A JPS5132725A JP S5132725 A JPS5132725 A JP S5132725A JP 50040754 A JP50040754 A JP 50040754A JP 4075475 A JP4075475 A JP 4075475A JP S5132725 A JPS5132725 A JP S5132725A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP50040754A
Inventor
Edogaa Suteyuwaato Uiriamu
Marii Hendoriku Furan D Pieeru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SUTEIHITEINGU REGA UE ZETSUTO
SUTEIHITEINGU REGA UE ZETSUTO BE
Original Assignee
SUTEIHITEINGU REGA UE ZETSUTO
SUTEIHITEINGU REGA UE ZETSUTO BE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SUTEIHITEINGU REGA UE ZETSUTO, SUTEIHITEINGU REGA UE ZETSUTO BE filed Critical SUTEIHITEINGU REGA UE ZETSUTO
Publication of JPS5132725A publication Critical patent/JPS5132725A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP50040754A 1974-04-03 1975-04-03 Pending JPS5132725A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7404589A NL7404589A (nl) 1974-04-03 1974-04-03 Werkwijze voor het stabiliseren van interferon.

Publications (1)

Publication Number Publication Date
JPS5132725A true JPS5132725A (ja) 1976-03-19

Family

ID=19821109

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50040754A Pending JPS5132725A (ja) 1974-04-03 1975-04-03

Country Status (11)

Country Link
US (1) US3981991A (ja)
JP (1) JPS5132725A (ja)
AU (1) AU7951275A (ja)
BE (1) BE826889A (ja)
DE (1) DE2514537A1 (ja)
DK (1) DK139775A (ja)
FI (1) FI750951A (ja)
FR (1) FR2266740B3 (ja)
NL (1) NL7404589A (ja)
NO (1) NO751118L (ja)
SE (1) SE7503769L (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58167520A (ja) * 1982-03-27 1983-10-03 Sunstar Inc インタ−フエロン安定配合製剤
JPS61277633A (ja) * 1985-05-31 1986-12-08 Toray Ind Inc インタ−フエロン組成物
JPS63146826A (ja) * 1986-07-18 1988-06-18 Chugai Pharmaceut Co Ltd 安定な顆粒球コロニ−刺激因子含有製剤

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4100150A (en) * 1975-11-04 1978-07-11 G. D. Searle & Co. Stabilization of interferon against mechanical stress using thioctic acid
FR2351665A1 (fr) * 1976-05-21 1977-12-16 Elf Aquitaine Procede de purification de preparations possedant notamment une activite interferon, preparations purifiees ainsi obtenues et leur application en tant que medicament
US4503035B1 (en) * 1978-11-24 1996-03-19 Hoffmann La Roche Protein purification process and product
IN150740B (ja) * 1978-11-24 1982-12-04 Hoffmann La Roche
US6410697B1 (en) 1979-04-20 2002-06-25 Schering Corporation Process for purifying human leukocyte interferon
US4289689A (en) * 1980-03-14 1981-09-15 Hoffmann-La Roche Inc. Preparation of homogeneous human fibroblast interferon
US4252791A (en) * 1979-10-19 1981-02-24 The Medical College Of Wisconsin, Inc. Interferon stabilization
FI88175C (fi) 1980-04-03 1993-04-13 Biogen Inc Rekombinant-dna-molekyler och foerfaranden foer framstaellning av polypeptider liknande humant -interferon
EP0077063B1 (en) * 1981-10-13 1988-03-16 Exovir, Inc. Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
US5582824A (en) * 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
DE3273597D1 (en) * 1981-11-28 1986-11-06 Sunstar Kk Pharmaceutical composition containing interferon in stable state
US5702699A (en) * 1982-09-23 1997-12-30 Cetus Corporation Process for the recovery of lipophilic proteins
US4476049A (en) * 1983-09-20 1984-10-09 Hoffmann-La Roche Inc. Method for the extraction of immune interferon
US4681930A (en) * 1983-09-20 1987-07-21 Hoffmann-La Roche Inc. Immune interferon and a method for its extraction and purification
ZA846554B (en) * 1983-09-20 1985-04-24 Hoffmann La Roche Immune interferon and method for its purification
JPS6079000A (ja) * 1983-10-04 1985-05-04 Takeda Chem Ind Ltd ヒトγ型インタ−フエロン単量体の製造法
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
MX9203641A (es) * 1983-12-16 1992-07-01 Genentech Inc Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
IL74093A0 (en) * 1984-01-23 1985-04-30 Takeda Chemical Industries Ltd Stable composition of gamma-interferon
HU193472B (en) * 1984-09-21 1987-10-28 Vni Sky I Osobo Chistkykh Biop Process for purification of human leucocite interferon
US4950470A (en) * 1986-10-06 1990-08-21 Board Of Regents, The University Of Texas System Methods and compositions employing interferon-gamma
US5165921A (en) * 1989-01-23 1992-11-24 National Geno Sciences, Inc. Method for treating condyloma acuminatum with interferon
US5236707A (en) * 1991-11-08 1993-08-17 Dallas Biotherapeutics, Inc. Stabilization of human interferon
US6399296B1 (en) * 1994-07-20 2002-06-04 The General Hospital Corporation Interaction trap systems for detecting protein interactions
GB0002660D0 (en) * 2000-02-04 2000-03-29 Biomade B V Method of stabilizing a hydrophobin-containing solution and a method of coatinga surface with a hydrophobin
AR034749A1 (es) * 2001-07-09 2004-03-17 Schering Ag Formulaciones de interferon beta humano

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58167520A (ja) * 1982-03-27 1983-10-03 Sunstar Inc インタ−フエロン安定配合製剤
JPS61277633A (ja) * 1985-05-31 1986-12-08 Toray Ind Inc インタ−フエロン組成物
JPS63146826A (ja) * 1986-07-18 1988-06-18 Chugai Pharmaceut Co Ltd 安定な顆粒球コロニ−刺激因子含有製剤

Also Published As

Publication number Publication date
FI750951A (ja) 1975-10-04
US3981991A (en) 1976-09-21
NO751118L (ja) 1975-10-06
NL7404589A (nl) 1975-10-07
SE7503769L (sv) 1975-10-06
DE2514537A1 (de) 1975-10-09
BE826889A (nl) 1975-09-22
FR2266740A1 (ja) 1975-10-31
AU7951275A (en) 1976-09-30
DK139775A (ja) 1975-10-04
FR2266740B3 (ja) 1977-12-16

Similar Documents

Publication Publication Date Title
JPS5132725A (ja)
AU495930B2 (ja)
CH41675A4 (ja)
AU480247A (ja)
AU480471A (ja)
AU480758A (ja)
AU480863A (ja)
BG19768A1 (ja)
BG19847A1 (ja)
BG19987A1 (ja)
BG20440A1 (ja)
AU479931A (ja)
BG20451A1 (ja)
BG20462A1 (ja)
BG20638A1 (ja)
BG20854A1 (ja)
BG20883A1 (ja)
BG20885A1 (ja)
BG20950A1 (ja)
BG21129A1 (ja)
BG21307A1 (ja)
BG21351A1 (ja)
BG21352A1 (ja)
BG21526A1 (ja)
BG21634A1 (ja)